LONDON, UK
In a decisive move to strengthen public health defenses, the UK government has scrapped seasonal restrictions on prescribing flu medications, enabling doctors and pharmacists to respond to outbreaks throughout the year.
Previously, clinicians were required to wait for an annual directive from the Chief Medical Officer before prescribing antivirals like oseltamivir (Tamiflu®) and zanamivir (Relenza®) outside the October–March flu season. This delay often hindered timely treatment and outbreak containment.
Under the new policy, frontline healthcare providers can now prescribe these medications year-round, especially in high-risk settings such as care homes. The change is part of the government’s broader “Red Tape Challenge” initiative, aimed at reducing bureaucracy and empowering clinical decision-making.
Health Minister Stephen Kinnock emphasized that flu doesn’t follow a calendar, and neither should access to treatment. “We’re removing unnecessary hurdles so clinicians can act swiftly to protect vulnerable communities,” he stated.
The announcement coincides with the launch of the NHS’s autumn vaccination campaign, which includes expanded flu vaccine access for children, pregnant women, and those in clinical risk groups. The National Booking System is now open for flu and COVID-19 vaccination appointments.
Dr. Jamie Lopez Bernal of the UK Health Security Agency noted that while most flu outbreaks occur in winter, off-season cases still pose serious risks. “This reform allows faster, more effective responses to emerging threats,” he said.